Hematology Analyzers and Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product And Services, By End User, By Application, By Region & Competition, 2021-2031F

Description

The Global Hematology Analyzers and Reagents Market is projected to expand from USD 2.32 Billion in 2025 to USD 3.51 Billion by 2031, registering a CAGR of 7.14%. Hematology analyzers act as automated systems for blood cell counting and morphology analysis, while reagents serve as the vital chemical solutions that enable these diagnostic procedures. The primary factor driving this market is the growing global prevalence of blood disorders, such as leukemia and anemia, which creates a sustained demand for high-volume, accurate testing. This need is further amplified by the push for high-throughput automation within clinical laboratories to enhance operational efficiency. Highlighting this urgency, the American Cancer Society estimates that 66,890 new cases of leukemia will be diagnosed in the United States in 2025, necessitating robust diagnostic capabilities.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 2.32 Billion
Market Size 2031	USD 3.51 Billion
CAGR 2026-2031	7.14%
Fastest Growing Segment	Hemoglobin Analyzers
Largest Market	North America

Despite this upward trajectory, the market encounters a substantial hurdle due to the high capital costs associated with purchasing and maintaining advanced hematology systems. This financial requirement restricts adoption rates, particularly among smaller independent laboratories and healthcare facilities in emerging markets that operate with limited budgets. Furthermore, complex and divergent regulatory environments across different regions can postpone the approval and market entry of innovative diagnostic technologies, thereby slowing the overall pace of industry expansion.

Market Driver

The incorporation of artificial intelligence and digital imaging technologies is transforming the market by significantly improving diagnostic accuracy and laboratory workflow. By utilizing AI-driven algorithms, laboratories can automate the morphological examination of blood cells, reducing the dependency on manual microscopy and mitigating the risk of human error. This technological evolution enables faster turnaround times and more consistent outcomes, which is essential for high-volume testing centers. A notable development in this sector was reported by Scopio Labs in July 2025, when the company obtained FDA clearance for an AI-powered application capable of analyzing red blood cell morphology and platelet clumps, thereby optimizing digital hematology processes.

Simultaneously, the rising adoption of automated and integrated hematology workstations is fueling market growth as clinical laboratories aim to consolidate their testing operations. High-throughput analyzers that integrate cell counting, slide preparation, and staining into a single platform are becoming indispensable for managing growing sample volumes amidst staffing constraints. This shift toward automation is reflected in the financial results of key industry players; for instance, Mindray reported in April 2025 that its In-Vitro Diagnostics revenue increased by nearly 11% in 2024, leading its divisions due to robust demand for automated solutions. Additionally, NHS England data from August 2025 indicated that over 1.6 million extra diagnostic tests and scans were conducted between July 2024 and June 2025 compared to the prior year, underscoring the vital need for efficient infrastructure.

Market Challenge

The substantial capital investment necessary to acquire and maintain sophisticated hematology analyzers acts as a major restraint on the market. These diagnostic systems require significant upfront expenditure, which is often prohibitive for smaller independent laboratories and healthcare facilities operating with constrained budgets. Beyond the initial purchase price, the ongoing cumulative costs of proprietary reagents, service agreements, and operator training place further stress on financial resources. Consequently, many institutions are compelled to extend the lifespan of older equipment rather than upgrading to newer, more efficient automation, thereby slowing the replacement rate required for market momentum.

This economic pressure directly hampers the adoption of next-generation diagnostic technologies. According to the American Hospital Association, in 2025, 94% of healthcare administrators anticipated delaying equipment upgrades to manage financial challenges. Such reluctance to invest in capital assets limits the number of new system installations and restricts revenue growth for manufacturers. As a result, the market experiences a slowdown in the proliferation of advanced hematology solutions, as purchasing decisions are frequently deferred to conserve operational capital.

Market Trends

The growing utilization of point-of-care (POC) hematology testing is reshaping the market by decentralizing diagnostic capabilities and accelerating results in critical care settings. Healthcare facilities are increasingly adopting compact, portable analyzers that employ microfluidic technology to perform lab-quality complete blood counts directly at the patient's bedside, thereby eliminating the logistical delays associated with central laboratories. This transition is particularly significant in emergency departments where rapid clinical decisions are crucial; for example, a case study by PixCell Medical in June 2025, titled 'Transforming Emergency Care in Chile with HemoScreen CBC Testing,' demonstrated that their point-of-care analyzer provided results in under 10 minutes, averaging 20 minutes faster than traditional laboratory testing.

In parallel, the introduction of novel clinical parameters and biomarkers is driving demand for advanced reagents and high-sensitivity analysis. Laboratories are moving beyond standard cell counts to incorporate advanced metrics such as immature platelet fraction and reticulocyte hemoglobin, which offer deeper insights into conditions like sepsis and anemia. This focus on detailed cellular profiling requires the consumption of specialized, high-value proprietary reagents, directly boosting manufacturer revenues. This trend is evident in Sysmex Corporation's May 2025 report, 'Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025,' which noted a 17.6% year-on-year increase in hematology segment sales within the Asia Pacific region, attributed largely to the rising demand for diagnostic instruments and reagents.

Key Market Players

Sysmex Corporation
Danaher Corporation
Nihon Kohden Corporation
Siemens Healthineers AG
Abbott Laboratories
Boule Diagnostics AB
Bio-Rad Laboratories Inc.
Biosystems S.A.
EKF Diagnostics Holdings Plc
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Report Scope

In this report, the Global Hematology Analyzers and Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hematology Analyzers and Reagents Market, By Product And Services

Hematology
Hemostasis
Immunohematology
Plasma Protein Analyzer
Hemoglobin Analyzers
Erythrocyte Sedimentation Rate Analyzer
Coagulation Analyzer
Flow Cytometers
Differential Counters

Hematology Analyzers and Reagents Market, By End User

Hospital Laboratories
Blood Banks
Research and Academic Institute
Others

Hematology Analyzers and Reagents Market, By Application

Anemia
Blood Cancer
Hemorrhagic Conditions
Infection-Related Conditions
Immune-System Related Conditions
Others

Hematology Analyzers and Reagents Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hematology Analyzers and Reagents Market.

Available Customizations:

Global Hematology Analyzers and Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hematology Analyzers and Reagents Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product And Services (Hematology, Hemostasis, Immunohematology, Plasma Protein Analyzer, Hemoglobin Analyzers, Erythrocyte Sedimentation Rate Analyzer, Coagulation Analyzer, Flow Cytometers, Differential Counters)
- 5.2.2. By End User (Hospital Laboratories, Blood Banks, Research and Academic Institute, Others)
- 5.2.3. By Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection-Related Conditions, Immune-System Related Conditions, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2025)
5.3. Market Map

6. North America Hematology Analyzers and Reagents Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product And Services
- 6.2.2. By End User
- 6.2.3. By Application
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Hematology Analyzers and Reagents Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product And Services
    - 6.3.1.2.2. By End User
    - 6.3.1.2.3. By Application
- 6.3.2. Canada Hematology Analyzers and Reagents Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product And Services
    - 6.3.2.2.2. By End User
    - 6.3.2.2.3. By Application
- 6.3.3. Mexico Hematology Analyzers and Reagents Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product And Services
    - 6.3.3.2.2. By End User
    - 6.3.3.2.3. By Application

7. Europe Hematology Analyzers and Reagents Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product And Services
- 7.2.2. By End User
- 7.2.3. By Application
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Hematology Analyzers and Reagents Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product And Services
    - 7.3.1.2.2. By End User
    - 7.3.1.2.3. By Application
- 7.3.2. France Hematology Analyzers and Reagents Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product And Services
    - 7.3.2.2.2. By End User
    - 7.3.2.2.3. By Application
- 7.3.3. United Kingdom Hematology Analyzers and Reagents Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product And Services
    - 7.3.3.2.2. By End User
    - 7.3.3.2.3. By Application
- 7.3.4. Italy Hematology Analyzers and Reagents Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product And Services
    - 7.3.4.2.2. By End User
    - 7.3.4.2.3. By Application
- 7.3.5. Spain Hematology Analyzers and Reagents Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product And Services
    - 7.3.5.2.2. By End User
    - 7.3.5.2.3. By Application

8. Asia Pacific Hematology Analyzers and Reagents Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product And Services
- 8.2.2. By End User
- 8.2.3. By Application
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Hematology Analyzers and Reagents Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product And Services
    - 8.3.1.2.2. By End User
    - 8.3.1.2.3. By Application
- 8.3.2. India Hematology Analyzers and Reagents Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product And Services
    - 8.3.2.2.2. By End User
    - 8.3.2.2.3. By Application
- 8.3.3. Japan Hematology Analyzers and Reagents Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product And Services
    - 8.3.3.2.2. By End User
    - 8.3.3.2.3. By Application
- 8.3.4. South Korea Hematology Analyzers and Reagents Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product And Services
    - 8.3.4.2.2. By End User
    - 8.3.4.2.3. By Application
- 8.3.5. Australia Hematology Analyzers and Reagents Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product And Services
    - 8.3.5.2.2. By End User
    - 8.3.5.2.3. By Application

9. Middle East & Africa Hematology Analyzers and Reagents Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product And Services
- 9.2.2. By End User
- 9.2.3. By Application
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Hematology Analyzers and Reagents Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product And Services
    - 9.3.1.2.2. By End User
    - 9.3.1.2.3. By Application
- 9.3.2. UAE Hematology Analyzers and Reagents Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product And Services
    - 9.3.2.2.2. By End User
    - 9.3.2.2.3. By Application
- 9.3.3. South Africa Hematology Analyzers and Reagents Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product And Services
    - 9.3.3.2.2. By End User
    - 9.3.3.2.3. By Application

10. South America Hematology Analyzers and Reagents Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product And Services
- 10.2.2. By End User
- 10.2.3. By Application
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Hematology Analyzers and Reagents Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product And Services
    - 10.3.1.2.2. By End User
    - 10.3.1.2.3. By Application
- 10.3.2. Colombia Hematology Analyzers and Reagents Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product And Services
    - 10.3.2.2.2. By End User
    - 10.3.2.2.3. By Application
- 10.3.3. Argentina Hematology Analyzers and Reagents Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product And Services
    - 10.3.3.2.2. By End User
    - 10.3.3.2.3. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Hematology Analyzers and Reagents Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Sysmex Corporation
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Danaher Corporation
15.3. Nihon Kohden Corporation
15.4. Siemens Healthineers AG
15.5. Abbott Laboratories
15.6. Boule Diagnostics AB
15.7. Bio-Rad Laboratories Inc.
15.8. Biosystems S.A.
15.9. EKF Diagnostics Holdings Plc
15.10. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.